# Plasma Nutrition

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/plasma-nutrition

- Industry: Biotechnology
- Headquarters: Sarasota, US
- Website: www.becomeio.com
- Latest round: Series A (Nov 3, 2021)
- Investors on record: 2

## About

Plasma Nutrition Inc. is a biotechnology firm focused on enhancing protein solutions to improve nutrient absorption and health benefits through innovative methods and proprietary technology.Plasma Nutrition Inc., founded in 2015 by Chris Flynn-Rozanski and Stephen Motosko, is based in Sarasota, US. The company specializes in advanced protein solutions aimed at improving nutrient absorption. The most recent funding round was a SERIES A in November 2021, with participation from Continental Grain Company and SOSV, and the deal overview indicates that the funding will support the development and expansion of the company’s technology. Ingredient Optimized® is a biotechnology company specializing in advanced protein solutions aimed at enhancing nutrient absorption and overall health outcomes. The company's core product offerings include ioWhey®, ioPea™, ioBCAA™, and ioCollagen™, all formulated with proprietary Ingredient Optimized® technology, which utilizes non-thermal atmospheric plasma to enhance protein bioavailability by 3-5 times compared to standard isolates. These products are designed to improve athletic performance, reduce digestive discomfort, and enhance flavor profiles for a diverse customer base that includes athletes, fitness enthusiasts, and health-conscious consumers, marketed across North America and Europe.Ingredient Optimized® generates revenue through direct-to-consumer sales and partnerships with retailers and wholesalers, allowing broad distribution of flagship products like ioWhey® and ioCollagen™. The pricing strategy offers competitive rates for consumers while ensuring healthy margins for partners, capitalizing on a recurring demand for high-quality protein supplements supported by clinical research.Plasma Nutrition Inc. plans to leverage its recent SERIES A funding raised in November 2021 to support the development of new products and expand its technological capabilities. The company aims to launch several new protein formulations targeted at health and fitness markets in 2023. Additionally, it seeks to enter new geographic regions, specifically targeting the Asian market by 2024, to broaden its reach and enhance accessibility to its innovative nutritional solutions.

## Funding rounds

- Series A, Nov 3, 2021 — SOSV, Conti Ventures

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Series A
- Conti Ventures — Series A